Product Information
TROSPIUM CHLORIDE ER 60 MG CAP is a generic product labeled by Padagis US LLC, priced at $1.6430 per EA under NDC 00574011830. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 24, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Padagis US LLCNDC
00574011830
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TROSPIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201291FDA Approved
5/24/2013
TE Code
AB
On Market Since
6/7/2013
Pharmacological Classes
Price Statistics
The NADAC for TROSPIUM CHLORIDE ER 60 MG CAP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6430 per EA |
|---|---|
| All-time high | $5.4731 (Sep 10, 2014) |
| All-time low | $1.5910 (Nov 20, 2024) |
| 52-week high | $2.0448 |
| 52-week low | $1.6430 |
| Median price | $4.0927 |
| Average price | $3.7039 |
| Largest weekly change | +44.7% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trospium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TROSPIUM CHLORIDE ER 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for TROSPIUM CHLORIDE ER 60 MG CAP, manufactured by Padagis US LLC, is $1.6430 per EA (NDC 00574011830), effective Sep 30, 2026.
How has the price of TROSPIUM CHLORIDE ER 60 MG CAP changed over time?
Over the history we have for it, the NADAC for TROSPIUM CHLORIDE ER 60 MG CAP has declined 67.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TROSPIUM CHLORIDE ER 60 MG CAP?
Since Nov 28, 2013, the NADAC for TROSPIUM CHLORIDE ER 60 MG CAP has ranged from a low of $1.5910 (Nov 20, 2024) to a high of $5.4731 (Sep 10, 2014), with a median of $4.0927 per EA.
Are there cheaper alternatives to TROSPIUM CHLORIDE ER 60 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TROSPIUM CHLORIDE ER 60 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures TROSPIUM CHLORIDE ER 60 MG CAP?
TROSPIUM CHLORIDE ER 60 MG CAP (NDC 00574011830) is labeled by Padagis US LLC, and CMS classifies it as a generic product.